Personal HistoryDr. Zimrin graduated from the University of Chicago Pritzker School of Medicine and trained in Internal Medicine at University of California, San Franscisco. She completed a fellowship in Hematology/Oncology at the University of Pennsylvania, finishing in 1989. She is board certified in Hematology and Medical Oncology.
Research InterestsDr. Zimrin is involved in a number of clinical trials, both within the University of Maryland and nationally, investigating novel treatment options for lymphoma and head and neck cancer.
Dr. Zimrin's clinical interests include disorders of the coagulation system and other benign hematologic conditions.
Peer-Reviewed Journal Articles
Golomb HM, Testa JR, Vardiman JW, Butler AE, Rowley JD. Cytogenetic and ultrastructural features of de novo acute promyelocytic leukemia: The University of Chicago experience (1973-1978). Cancer Genet & Cytogenet 1:69-78, 1979.
Golomb HM, Rowley JD, Vardiman JW, Testa JR, Butler AE. Microgranular acute promyelocytic leukemia: A distinct clinical, ultratructural and cytogenetic entity. Blood 55:253-259, 1980.
Butler (Zimrin) AE, Vardiman JW, Golomb HM. Ultrastructural characterization of de novo and secondary leukemias. Virchows Archiv (Cell Pathol) 39:239-257, 1982.
Larson RA, Kondol R, Vardiman JW, Butler (Zimrin) AE, Golomb HM, Rowley JR. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. AM J Med 76:827-841, 1984.
Zimrin AB, Eisman R, Vilaire G, Schwarz E, Bennett JS, Poncz M. The structure of platelet glycoprotein IIIa: A common subunit for two different membrane receptors. J Clin Invest 81:1470-1475, 1988.
Zimrin AB, Gidwitz S, Lord S, Schwatz E, Bennett JS, Poncz M. The genomic organization of platelet glycoprotein IIIa. J Biol Chem 265:8590-8595, 1990.
Maciag T, Zhan W, Garfinkel S, Friedman S, Prodovsky I, Jackson A, Wessendorf J, Hu X, Gamble S, Shi J, Brown S, Tarantini F, Zimrin A. Novel mechanisms of fibroblast growth factor I function. Hormone Res 49:105-123, 1994.
Zimrin AB, Villeponteau B, Maciag T. Models of in vitro angiogenesis: Endothelial cell differentiation on fibrin but not matrigel is transcriptionally dependent. Biochem Biophys Res Commun 213:630-638, 1995.
Zimrin AB, Maciag T. Progress towards a unifying hypothesis for angiogenesis. J Clin Invest 97:1359, 1996.
Zimrin AB, Pepper MS, McMahon GA, Nguyen F, Montesano R, Maciag T. An antisense oligonucleotide to the Notch ligand Jagged enhances fibroblast growth factor-induced angiogenesis in vitro. J Biol Chem 271:32499-32502, 1997.
Hla T, Zimrin AB, Evans M, Ballas K, Maciag T. The immediate-early gene product MAD-3/EDG-3lkBa is an endogenous modulator of fibroblast factor-I dependent human endothelial cell growth. FEBS Letters 414:419-424, 1997.
Zimrin AB, Dutton RP, McCunn M, Hess JR. Management of postinjury coagulopathy. TATM 2005;6:37-41.
Badros A, Porter N, and Zimrin A: Bevacizumab therapy for POEMS syndrome. Blood 2005;106:1135.
Hess JR, Zimrin AB: Massive blood transfusion for trauma. Curr Opin Hematol 2005:12:488-92.
Zimrin AB, Hess JR: TTP: Going with the evidence. Crit Care Med 2006;34:2247-8.
Chumsri S, Zimrin AB, Gibble JW, Hess JR. Ce ntro-lobular lung edema in probable transfusion -related acute lung injury. Transfusion 2006; 47:183.
Zimrin AB, Hess JH. Planning for Pandemic Influenza: Effect of a pandemic on the supply and demand for blood products in the U.S.. Transfusion 2007
Zimrin AB, Holcomb JB, Hess JR. Hemorrhage control and thrombosis following severe injury. Chap 47 in Kitchens CS, Alving BM, Kestler CM, eds. Consultative Hemostasis and Thrombosis, 2nd Edition. Philadelphia, Saunders, 2006 (accepted for publication).
Butler (Zimrin) AE, Vardiman JW, Golomb HM. Blast crisis of chronic myelocytic leukemia: Ultrastructural features. 37th Ann Proc Electron Microscopy Soc Amer 232, 1979.
Mintz UI, Selhub J, Butler (Zimrin) AE, Golomb HM. Vitamin BI2 binding proteins in hairy cell leukemia and other lymphoproliferative disorders. Clin Res 27:301a, 1979.
Butler (Zimrin) AE, Golomb HM, Vardiman JW. Ultrastructural classification of leukemias arising as a second malignancy. Clin Res 27, 636a 1979.
Butler (Zimrin) AE, Golomb HM, Vardiman JW. Ultrastuctural classification of acute leukemias. Proc Amer Assoc for Cancer Res 21:171a, 1980.
Butler-Zimrin AE, Eisman R, Surrey S, Heidenriech RA, Vilaire G, Schwartz E, Bennett 1M, Poncz M. Isolation and characterization of cDNA clones for the platelet membrane glycoproteins IIb and IIIa. Clin Res 36:597a, 1987.
Zimrin AB, Heidenriech R, Eisman R, Bennett JS, Schwartz E, Poncz M. Isolation and characterization of the genes for human platelet glycoprotein IIib and IIIa. Clin Res 36:571a, 1988.
Zimrin AB, Maciag T. Endothelial cell differentiation on matrigel may not require a transcriptional event. J Cell Biol 111:147a, 1990.
Zimrin AB, Engleka KA, Maciag T. Effect of a pseudomonas toxin-acidic fibroblast growth facto chimera on the growth of A431 cells and BALB 3T3 cells. VIIth International Symposium on the Biology of Vascular Cells.
Zimrin AB, Austin E, Maciag T. Isolation of novel cDNAs from endothelial cells induced to differentiate by plating on fibrin gels. Blood 82 (10, suppl 1):276a, 1993.
Zimrin AB, Pepper MS, Montesano R, Maciag T. An antisense oligonucleotide to the Notch ligand Jagged promtes angiogenesis in bovine microvascular endothelial cells (BMEC) on collagen gels. FASEB J 10(6):A1094, 1996.
Zimrin AB, Wong MKK, Maciag T. Characterization of a soluble Jagged transcript from human endothelial cells. Molec Biol Cell 8:229a, 1997
Lee E, Zamkoff, Gentile TC and Zimrin A. Rituxan in the treatment of auto-immune hemolytic anemia. Blood 960-596a, 2000.